RXRX vs SGEN
Recursion Pharmaceuticals Inc (RXRX) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
SGEN (SGEN) common stock.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
SGEN does not have a complete income-statement cache yet.
RXRX currently screens at market cap $1.75B.
Not investment advice. Open the RXRX and SGEN stock pages for the full models.
Not investment advice.